Table 3

- Pathological diagnosis of the patients.

Pathological diagnosisn (%)
Tumours of uterine corpus135 (67.5)
Epithelial tumours117 (86.7)
Clear cell carcinoma3 (2.6)
Endometrioid carcinoma106 (90.6)
Serous carcinoma5 (4.3)
Small cell neuroendocrine carcinoma1 (0.9)
Undifferentiated carcinoma2 (1.7)
Mesenchymal tumours13 (9.6)
Endometrial stromal sarcoma, high-grade2 (15.4)
Endometrial stromal sarcoma, low-grade6 (46.2)
Leiomyosarcoma4 (30.8)
Undifferentiated sarcoma1 (7.7)
Mixed epithelial and mesenchymal tumours5 (3.7)
Carcinosarcoma2 (40.0)
Mixed cell carcinoma3 (60.0)
Ovarian neoplasm27 (13.5)
Epithelial tumours borderline6 (22.2)
Mucinous borderline tumor with microinvasion2 (33.3)
Serous borderline tumor2 (33.3)
Serous borderline tumor, micropapillary variant2 (33.3)
Epithelial tumours malignant10 (37.0)
Endometrioid carcinoma1 (10.0)
Mucinous adenocarcinoma3 (30.0)
Serous carcinoma6 (60.0)
Sex-cord tumours6 (22.2)
Adult granulosa cell tumor5 (83.3)
Juvenile granulosa tumour1 (16.7)
Germ cell tumours3 (11.1)
Dysgerminoma2 (66.7)
Immature teratoma1 (33.3)
Plasmacytoma1 (3.7)
Plasmacytoma1 (100)
Secondary tumours1 (3.7)
Metastatic carcinoma1 (100)
Tumour of uterine cervix27 (13.5)
Clear cell carcinoma1 (3.7)
Squamous cell carcinoma24 (88.9)
Undifferentiated carcinoma2 (7.4)
Valvar and vaginal tumours8 (4.0)
Botryoid rhabdomyosarcoma1 (12.5)
Squamous cell carcinoma7 (87.5)
Gestational trophoblastic neoplasm3 (1.5)
Choriocarcinoma1 (33.3)
Epithelioid trophoblastic tumor1 (33.3)
Gestational choriocarcinoma1 (33.3)